As of Apr 27
| +0.86 / +0.81%|
The 7 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 115.00, with a high estimate of 140.00 and a low estimate of 105.00. The median estimate represents a +7.86% increase from the last price of 106.62.
The current consensus among 8 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.